A written ministerial statement from the Cabinet Office has been published this afternoon, along with a letter giving an update on the Government’s 'no deal' planning and guidance.
The Office for Life Sciences has today published its annual Life Science Competitiveness Indicators, which highlight the importance of the Industry to the UK economy.
Outgoing Chief Medical Officer Professor Dame Sally Davies has been named as UK Special Envoy on antimicrobial resistance (AMR), working across all sectors including includes health, agriculture and the environment to tackle the global health threat.
The NHS Confederation and the ABPI have today published a new report to help the NHS and life sciences industry work more closely together.
The ABPI has published a new guide for pharmaceutical companies working with patients.
The ABPI welcomes the news of the Government’s decision to reject three significant recommendations made by the Cost-Effectiveness Methodology for Immunisation Programmes and Procurement (CEMIPP) group following consultation with charities, patient groups, health bodies and organisations, and...
In National Careers Week, Charlotte Hardy, medicinal chemist from GSK gives her perspective on what it’s like to work in the pharmaceutical sector
There has been much discussion in recent days on medicines pricing in the UK. The UK has some of the most robust processes in the world for ensuring value for money on medicines.
Today, 4 June, sees the unveiling of the UK’s newest life sciences asset, Health Innovation Research Alliance Northern Ireland (HIRANI) at a BIO reception in Philadelphia.
In light of the Government's announcement of an extension to article 50, ABPI commented on the position regarding stockpiling of medicines in preparation for a 'no-deal'.